Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quantianma Jiaonang is a traditional Chinese medicine (TCM) capsule formulation indicated for the treatment of vertigo or headache attributed to "liver wind" in TCM theory. The product is manufactured by Guizhou Shengshilongfang Pharmaceutical and has received approval from the Chinese Food and Drug Administration (approval number Z52020425). Its mechanism of action is based on TCM principles rather than modern pharmacology; it likely contains herbal ingredients such as Gastrodia elata (Tian Ma), which is commonly used in China for neurological symptoms like dizziness and headaches. There are no published data on its precise molecular targets or mechanisms according to Western medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quantianma jiaonang.